Screener
Collegium Pharmaceutical, Inc. COLL Amortization of capitalized software and acquired intangible assets
Amortization of capitalized software and acquired intangible assets at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenues, net | $199,878 | $188,000 | $393,398 | $365,757 |
| Cost of product revenues | ||||
| Cost of product revenues (excluding intangible asset amortization) | 26,633 | 24,143 | 47,434 | 49,103 |
| Intangible asset amortization | 62,953 | 55,473 | 118,426 | 110,946 |
| Total cost of product revenues | 89,586 | 79,616 | 165,860 | 160,049 |
| Gross profit | 110,292 | 108,384 | 227,538 | 205,708 |
| Operating expenses | ||||
| Selling, general and administrative | 106,594 | 73,637 | 192,944 | 150,060 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets?
- Collegium Pharmaceutical, Inc. (COLL) reported amortization of capitalized software and acquired intangible assets of $62.95M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets changed year-over-year?
- Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets increased by 13.5% year-over-year, from $55.47M to $62.95M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets?
- Over 2 years (2021 to 2024), Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets has grown at a 56.9% compound annual growth rate (CAGR), from $67.18M to $165.3M.
- What does amortization of capitalized software and acquired intangible assets mean?
- Amortization of capitalized software and acquired intangible assets
Ask your AI about Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude